日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models

时间序列聚类捕捉到早期免疫效应细胞相关血液毒性的模式,这些模式可使用基于树的模型进行预测。

Liang, Emily C; Jeon, Yein; Qiao, Yang; Wu, Xiancheng; Huang, Jennifer J; Portuguese, Andrew J; Basom, Ryan; Torkelson, Aiko; Kirchmeier, Delaney; Braathen, Kristina; Cowan, Andrew J; Shadman, Mazyar; Hirayama, Alexandre V; Till, Brian G; Kimble, Erik L; Wu, Qian; Gauthier, Jordan

Competition for CD19 binding may accelerate CAR efficacy

竞争CD19结合位点可能加速CAR疗效

Hirayama, Alexandre V; Bleakley, Marie

Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow-up

真实世界中 lisocabtagene maraleucel 和 axicabtagene ciloleucel 在大 B 细胞淋巴瘤中的比较:一项为期 3 年的逆概率加权分析

Portuguese, Andrew J; Huang, Jennifer J; Jeon, Yein; Taheri, Mahnoosh; Albittar, Aya; Liang, Emily C; Hirayama, Alexandre V; Kimble, Erik L; Iovino, Lorenzo; Poh, Christina; Gopal, Ajay K; Shadman, Mazyar; Till, Brian G; Milano, Filippo; Chapuis, Aude G; Otegbeye, Folashade; Cassaday, Ryan D; Basom, Ryan S; Wu, Qian Vicky; Maloney, David G; Gauthier, Jordan

Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma

髓外疾病与多发性骨髓瘤患者接受B细胞成熟抗原CAR-T细胞治疗后出现的严重毒性反应相关。

Portuguese, Andrew J; Liang, Emily C; Huang, Jennifer J; Jeon, Yein; Dima, Danai; Banerjee, Rahul; Kwok, Mary; Cicero, Kara I; Hirayama, Alexandre V; Basom, Ryan; Khouderchah, Christy; Shadman, Mazyar; Fong, Lawrence; Cowan, Andrew J; Gauthier, Jordan

Development and validation of predictive models of early immune effector cell-associated hematotoxicity

早期免疫效应细胞相关血液毒性预测模型的建立与验证

Liang, Emily C; Huang, Jennifer J; Portuguese, Andrew J; Ortiz-Maldonado, Valentín; Albittar, Aya; Wuliji, Natalie; Basom, Ryan; Jeon, Yein; Wu, Qian; Torkelson, Aiko; Kirchmeier, Delaney; Chutnik, Abigail; Pender, Barbara; Sorror, Mohamed; Hill, Joshua A; Kopmar, Noam E; Banerjee, Rahul; Cowan, Andrew J; Green, Damian; Gopal, Ajay K; Poh, Christina; Shadman, Mazyar; Hirayama, Alexandre V; Till, Brian G; Kimble, Erik L; Iovino, Lorenzo; Chapuis, Aude G; Otegbeye, Folashade; Cassaday, Ryan D; Milano, Filippo; Turtle, Cameron J; Maloney, David G; Gauthier, Jordan

Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL

一项针对初治成人B细胞急性淋巴细胞白血病患者的CD19 CAR T细胞疗法(携带全人源scFv)的I期研究

Gauthier, Jordan; Liang, Emily C; Huang, Jennifer J; Kimble, Erik L; Hirayama, Alexandre V; Fiorenza, Salvatore; Voutsinas, Jenna M; Wu, Qian Vicky; Jaeger-Ruckstuhl, Carla A; Pender, Barbara S; Kirchmeier, Delaney R; Torkelson, Aiko; Braathen, Kristina; Basom, Ryan; Shadman, Mazyar; Kopmar, Noam E; Cassaday, Ryan D; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J

Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia.

急性淋巴细胞白血病中外周血细胞计数低和促炎细胞因子升高提示 CD19 嵌合抗原受体 T 细胞反应不良

Burleigh Katelyn, Stratton Kelly G, Smith Jenny L, Jensen Michael C, Turtle Cameron J, Keenan Camille, Annesley Colleen, Summers Corinne, Webb-Robertson Bobbie-Jo, Hirayama Alexandre V, Gardner Rebecca A, Gustafson Heather H

Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study

利索卡巴他根马拉鲁塞治疗复发/难治性套细胞淋巴瘤:来自 TRANSCEND NHL 001(一项 I 期多中心无缝设计研究)套细胞淋巴瘤队列的主要分析

Wang, Michael; Siddiqi, Tanya; Gordon, Leo I; Kamdar, Manali; Lunning, Matthew; Hirayama, Alexandre V; Abramson, Jeremy S; Arnason, Jon; Ghosh, Nilanjan; Mehta, Amitkumar; Andreadis, Charalambos; Solomon, Scott R; Kostic, Ana; Dehner, Christine; Espinola, Ricardo; Peng, Lily; Ogasawara, Ken; Chattin, Amy; Eliason, Laurie; Palomba, M Lia

PD-L1(+) macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacy

PD-L1(+)巨噬细胞和肿瘤细胞的数量及其在治疗前大B细胞淋巴瘤微环境中与T细胞的接近程度会影响CD19 CAR-T细胞免疫疗法的疗效。

Hirayama, Alexandre V; Wright, Jocelyn H; Smythe, Kimberly S; Fiorenza, Salvatore; Shaw, Akira N; Gauthier, Jordan; Maloney, David G; Naresh, Kikkeri N; Yeung, Cecilia C S; Turtle, Cameron J

Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic

在诊所回答“医生,CAR-T疗法会导致癌症吗?”这个问题

Banerjee, Rahul; Poh, Christina; Hirayama, Alexandre V; Gauthier, Jordan; Cassaday, Ryan D; Shadman, Mazyar; Cowan, Andrew J; Till, Brian G; Green, Damian J; Kiem, Hans-Peter; Gopal, Ajay K; Maloney, David G